# Handoff — 2026-11-09 — Codex / PowerShell + Haspataal MCP

## Current state

The user requested all remaining Phase P9A screens 164–193. All are implemented. Tested commits include `3b70b76` (182), `037b90e` (183), `76389bf` (184), `cb1e4fc` (185), `f98a6e0` (186), `c8128bf` (187–193), and `b46a2e0` (November backend follow-up). The closing commit records evidence and proposal receipts only. No command, native profile, uncertain business write or source edit remains in progress.

The DEV server currently sets `home_visit_register` to `hidden` because home visits are `Available` with no active service or history. The menu gate and absence of register requests passed. The bilingual handbook images show that real unavailable state. No 187 proposal was filed. The next check is to run the 187 period, detail, F1 and notice journey on an authorised fixture with the service or retained history exposed. Keep the shared service state as authorised. The populated blood and maternity registers, blood reaction follow-up, physical printing and named human workspace, Urdu and editorial reviews remain pending. Owner home visit policy reads and the notice passed. The shared arrangements write was not exercised.

## Progress and checks

Implementation 1. DEV build `2026-11-07T10:03:18.175586+00:00`, contract `2bf245cdfd753209ff51`, rubric `b13e53759b20`. Startup overview, what_changed, guide, roadmap, my_progress, progress_proposals and issue answers were read. Current screen contracts, quality/design briefs and plans are saved in `docs/phase-p9a-2026-11-06/`. Earlier 164–181 commits and claims are listed in `docs/PHASE_P9A_IMPLEMENTATION.md`. Proposals 350–364 were accepted at the last review check, and 365–371 remained pending.

Proposals 372–376 cover 182–186, 377–382 cover 188–193, and 383–388 cover the newly tested tracking items in Reception, Admissions, ER and Ward, the screening rule and department directory. All were verified pending, awaiting human review on /docs -> My progress. Exact payloads and receipts are saved. Do not re-propose unchanged accepted or pending claims. No human Review code or portal signature was entered.

The 873-test suite passed. Final mandatory 192-screen handbook coverage, TypeScript, DEV build, release DEV exclusion and DEV restore passed after the scoped F1 focus fix. The focused Refresh button and field regressions passed on the real terminal. Logs are `artifacts/p9a-nov9-final-unit.log`, `artifacts/p9a-nov9-final-release.log`, `artifacts/p9a-nov9-final-dev.log`. Summaries and request references are in `final-verification.json`, `nov9-tracking-journey.json` and `nov9-tracking-build.json` under the evidence directory. Profiles restored preferences and signed out.

## Backend issues

Reports #56–#61 were marked Fixed on the current server build. Native Ops assignment and people-list reads, real Hina/Ops acknowledgement and Ops findings, exact four-desk tracking and fresh cross-desk appeal passed. Acknowledgement payload and PDF before the step returned 409 for the original withdrawn synthetic complaint. Incident screening now explains final source prerequisites. The named active-department filter returned its actual General Medicine actions. Earlier draft-death/certified-death proof is in the 177 evidence. No pre-existing complaint or death record was changed by these checks.

Reports #62 (`adr_report`), #63 (`blood_registers`) and #64 (`blood_center_registers`) were filed and acknowledged as New on 9 November. These are documentation omissions for selector sources. The existing permission-checked ADR incident list, historical blood stock list and period donation list each returned 200. Exact report payloads and receipts are saved with 189–191. Check backend replies next time before resubmitting.

## Confirmed synthetic records

* QA1 and QA2 are signed and final. Own checklist items 45 and 46 are retired at version 3. Actions 14 and 15 remain recorded. No signature should be repeated.
* Feedback FB-2026-00001 was created once after an original-key replay. Quality reviewed it once with GET-only recovery and assigned CAPA-2026-0016 to Nurse Hina. FB-2026-00002 names synthetic patient 8. Blank form downloads created no feedback.
* Education material 1 and preventive programme 1 are retired or no longer offered at version 2. No seeded entry or service state was changed.
* ADR incident INC-2026-00011, id 11, has the saved report, Paracetamol batch B-PCM-500-1, and one synthetic DRAP sending entry. Nothing was transmitted externally. First invalid ADR attempt was refused with 422 and reconciled as unsaved. The corrected PUT and one submission are confirmed. Labour column 34 is switched off at version 2 with its three choices kept.
* Complaint CMP-2026-00011, id 12, was recorded at Admissions, resolved by Quality, and appealed once at Reception. The pre-appeal detail was 403 and post-appeal detail was 200. Reception is the actual appeal receiver. All setup stages and the original-key replay are confirmed. Do not repeat the guarded tracking harness. The original 403 probe reset the UI before any appeal. The subsequent test preserved its evidence and used the first valid appeal intent.

## Environment and continuation

Use PowerShell, Node 24 and `npm.cmd`. Authorised local settings are in ignored `.dev-terminal.json`, `.codex/config.toml` and `.agents/mcp_config.json`. Do not print or stage credentials. Native journeys use `scripts/clinical-test-kit.mjs`. Do not build while a native profile is active. For lost replies, only retry retained idempotent writes with the original body and key. Versioned and state-guard writes reconcile by reads. Keep all DEV records synthetic and read `AGENTS.md` on takeover. Progress acceptance and workspace reviews belong to the authenticated human.
